Forge’s Piteri-Molina on AI, Ohio and what’s next for gene therapy manufacturing

BioSpace · 11/06 15:28 UTC

Samantha Piteri-Molina, a BioSpace 40 Under 40 honoree, helped steer Forge's sale to Ajinomoto. She sees opportunities in AI-driven analytics and Ohio's gene therapy ecosystem, with a responsibility to patients worldwide.

Read the original (BioSpace)

See it in the digest → ・ See this issue →